Fund moves
77 tracked managers disclosed the same change for Q1 2026. From a 13F filed Apr 16, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 12, 2026 · Filed Mar 23, 2026
An Elevance Health director sold $7.5K of Elevance Health shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$7,475
Shares × reported transaction price
43 days after results of Jan 28, 2026, 41 days before results of Apr 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $287.89 on Mar 12, 2026, within 5% of its 52-week low, after a 16% drop over the previous 30 trading days
52-week range $274.66 (Aug 1, 2025) to $452.69 (Apr 3, 2025), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $341.85 on Jan 28, 2026. Describes the past only, not a forecast
RSI 34, 14% under its 200-day average, 15% under its 50-day average, 36% below the 52-week high, 20-day volatility 43% a year, against the S&P 500: −8 points over 1 month, −10 points over 3 months, −8 points over 6 months
From the adjusted closes up to Mar 12, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.
MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | −0.4% | +1.3% |
| 30 days | +19.3% | +8.5% | +10.8% |
| 90 days | +36.0% | +14.0% | +22.0% |
| 180 days | +41.0% | +18.4% | +22.6% |
Past results only. Not a forecast.
Fund moves
77 tracked managers disclosed the same change for Q1 2026. From a 13F filed Apr 16, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
77 tracked managers disclosed the same change for Q1 2026. From a 13F filed Apr 13, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Mar 6 · filed 3 days laterNot reported under a pre-arranged trading plan
Elevance Health's & President, Commercial sold $911K of Elevance Health shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.